A recent study sought to identify FTD patients with TDP-43 accumulation from a large patient cohort, which included all of the most common subtypes of the disease. TDP-43 levels were measured from patients’ blood samples using a sensitive single-molecule array (Simoa) technology.
Click here for original story, Serum TDP-43 levels can help to identify common neuropathological changes associated with frontotemporal dementia
Source: ScienceDaily